| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 63323-695-04 | 63323-695 | HUMAN PRESCRIPTION DRUG | Acetylcysteine | ACETYLCYSTEINE | SOLUTION | ORAL; RESPIRATORY (INHALATION) | 20140331 | N/A | ANDA | ANDA204674 | Fresenius Kabi USA, LLC | ACETYLCYSTEINE | 100 mg/mL | 25 VIAL in 1 CARTON (63323-695-04) / 4 mL in 1 VIAL (63323-695-22) |
| 63323-693-10 | 63323-693 | HUMAN PRESCRIPTION DRUG | Acetylcysteine | ACETYLCYSTEINE | SOLUTION | ORAL; RESPIRATORY (INHALATION) | 20140331 | N/A | ANDA | ANDA204674 | Fresenius Kabi USA, LLC | ACETYLCYSTEINE | 100 mg/mL | 3 VIAL in 1 CARTON (63323-693-10) / 10 mL in 1 VIAL (63323-693-22) |
| 63323-691-30 | 63323-691 | HUMAN PRESCRIPTION DRUG | Acetylcysteine | ACETYLCYSTEINE | SOLUTION | ORAL; RESPIRATORY (INHALATION) | 20140331 | N/A | ANDA | ANDA204674 | Fresenius Kabi USA, LLC | ACETYLCYSTEINE | 100 mg/mL | 3 VIAL in 1 CARTON (63323-691-30) / 30 mL in 1 VIAL (63323-691-22) |